Allergology international : official journal of the Japanese Society of Allergology
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma.
The MENSA trial assessed the efficacy and safety of mepolizumab in patients with severe eosinophilic asthma. This report describes the efficacy and safety of mepolizumab in Japanese patients from MENSA. ⋯ Mepolizumab was efficacious and well tolerated in Japanese patients with severe eosinophilic asthma, producing similar responses to the overall MENSA population.